Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With

Heather Turner, CEO of New York-based LB Pharma, on developing a new schizophrenia drug designed to better cross the blood-brain barrier, be dosed once daily, and make it easier for patients to take long term.